PRNewsWire - Health

ADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025
REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting
ALPCO Announces the European Commercial Launch of FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay and Patient Enrollment in Pivotal US Clinical Trial for Automated Chemiluminescent Version
NEW GLOBAL OVARIAN CANCER RESEARCH CONSORTIUM JOINS FORCES WITH MICROSOFT'S AI FOR GOOD LAB TO LAUNCH FIRST-OF-ITS-KIND $1M+ GLOBAL GRANT TO IMPROVE SURVIVAL RATES